Evaluating Appropriateness of Prescribing of Long-Acting Risperidone for Injection in Acute Care Settings

Abstract

Background: Long-acting risperidone for injection is a secondgeneration antipsychotic indicated for the treatment of schizophrenia and related psychotic disorders. It is a relatively new agent with pharmacokinetic and dosing properties unlike those of conventional long-acting antipsychotic drugs administered by injection.